Published in Trans Am Ophthalmol Soc on January 01, 2006
[Perioperative conversion of oral anticoagulants to heparin (bridging) in ophthalmic medicine]. Ophthalmologe (2010) 1.39
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med (1994) 10.26
Management of anticoagulation before and after elective surgery. N Engl J Med (1997) 5.10
Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med (2003) 5.02
The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 3.75
Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. The European Atrial Fibrillation Trial Study Group. N Engl J Med (1995) 2.51
Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology (2003) 2.36
EVIDENCE FOR "REBOUND" HYPERCOAGULABILITY AFTER STOPPING ANTICOAGULANTS. Lancet (1964) 2.34
Standardizing the prothrombin time. Calibrating coagulation instruments as well as thromboplastin. Arch Pathol Lab Med (1993) 2.09
Dental surgery in anticoagulated patients. Arch Intern Med (1998) 2.03
Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism. Arch Intern Med (2004) 2.00
Oral anticoagulation and risk of death: a medical record linkage study. BMJ (2002) 1.56
The regulation of hemostasis: the protein C system. N Engl J Med (1986) 1.31
Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation. J Am Coll Cardiol (2004) 1.13
Bleeding risks of antithrombotic therapy. BMJ (2002) 1.12
Delayed suprachoroidal hemorrhage after glaucoma filtration procedures. Ophthalmology (2001) 1.10
Management of the anticoagulated patient for ophthalmic surgery. Eye (Lond) (1993) 1.10
Rebound after cessation of oral anticoagulant therapy: the biochemical evidence. Br J Haematol (1996) 1.07
Oral anticoagulants: pharmacodynamics, clinical indications and adverse effects. J Clin Pharmacol (1992) 1.04
Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genotype. Thromb Haemost (2004) 1.02
Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy. Am Heart J (2004) 1.01
Anticoagulants and cataract surgery. Ophthalmic Surg (1988) 0.99
Recurrence of venous thromboembolism. Surgery (1973) 0.98
The effects of aspirin and warfarin therapy on haemorrhage in vitreoretinal surgery. Acta Ophthalmol Scand (2003) 0.96
Phacoemulsification and lens implantation in patients treated with aspirin or warfarin. J Cataract Refract Surg (1998) 0.94
Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants--a prospective study. Thromb Haemost (1994) 0.94
Haemorrhage and risk factors associated with retrobulbar/peribulbar block: a prospective study in 1383 patients. Br J Anaesth (2000) 0.91
Warfarin therapy and cataract surgery. Clin Experiment Ophthalmol (2000) 0.86
Study of acute intraoperative suprachoroidal hemorrhage. J Cataract Refract Surg (1992) 0.85
Cataract surgery under systemic anticoagulant therapy with coumarin. Eur J Ophthalmol (2006) 0.84
Oculoplastic surgery in patients receiving warfarin: suggestions for management. Ophthal Plast Reconstr Surg (1996) 0.83
Surgery during anticoagulant treatment. The risk of increased bleeding in patients on oral anticoagulant treatment. Acta Med Scand (1963) 0.83
Ocular surgery on patients receiving long-term warfarin therapy. Am J Ophthalmol (1989) 0.82
Warfarin and cataract extraction. Br J Ophthalmol (1989) 0.80
Effect of warfarin therapy on bleeding during cataract surgery. J Cataract Refract Surg (2001) 0.78
Aspirin is a hazard for vitreoretinal surgery. Br J Ophthalmol (1996) 0.77
Hemorrhagic complications of oculoplastic surgery. Ophthal Plast Reconstr Surg (2002) 0.77
Management, during dental surgery, of patients on anticoagulants. Lancet (1966) 0.77
Anticoagulation therapy and ocular surgery. Ophthalmic Surg Lasers (1998) 0.76
Anticoagulants and cataract surgery. J Cataract Refract Surg (1988) 0.76
Outcome results in macular hole surgery: an evaluation of internal limiting membrane peeling with and without indocyanine green. Ophthalmology (2003) 1.93
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol (2005) 1.65
Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery. Arch Ophthalmol (2006) 1.42
Intravitreal bevacizumab for the treatment of refractory diabetic macular edema. Ophthalmic Surg Lasers Imaging (2010) 0.91
Intravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosis. Am J Ophthalmol (2008) 0.87
Pars plana vitrectomy versus combined pars plana vitrectomy and scleral buckle for primary repair of rhegmatogenous retinal detachment. Can J Ophthalmol (2011) 0.86
Triamcinolone-assisted internal limiting membrane peeling. Retina (2005) 0.85
Surgical removal of peripapillary choroidal neovascularization associated with age-related macular degeneration. Ophthalmic Surg Lasers Imaging (2005) 0.85
Bilateral choroiditis from Prototheca wickerhamii algaemia. Arch Ophthalmol (2005) 0.82
Visual outcomes and complications after multiple vitrectomies for diabetic vitreous hemorrhage. Retina (2004) 0.82
Serpiginouslike choroiditis in a patient with cardiac sarcoidosis. Retina (2003) 0.79
Bilateral macular detachments in X-linked retinoschisis. Arch Ophthalmol (2006) 0.76
Surgery for retinal detachment: does experience matter? Retina (2012) 0.75
X-linked retinochisis and outer retinal corrugations. Arch Ophthalmol (2007) 0.75
Outcome of macular hole surgery in diabetic patients with nonproliferative retinopathy. Retina (2004) 0.75
Purtscher's-like retinopathy in a patient with systemic lupus erythematosus. Ophthalmic Surg Lasers Imaging (2004) 0.75
Surgical outcome of scleral buckling compared with scleral buckling with vitrectomy for treatment of macula-off retinal detachment. Ophthalmic Surg Lasers Imaging (2009) 0.75
Acute macular neuroretinopathy and associated disc swelling and blind spot enlargement. Can J Ophthalmol (2003) 0.75
Treatment of neovascular age-related macular degeneration: past, present and future directions. Curr Opin Ophthalmol (2007) 0.75